trial
as of 2026-07-01Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia
NCTId NCT00847600
at a glance
Phase 4 · Completed
Enrollment 60 (estimated)
Sponsored by Sha'ar Menashe Mental Health Center
Primary completion 2010-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2009-03
Primary completion
2010-12
Eligibility
ALL · 18 Years · 40 Years
Interventions & indications
Sponsors
Sha'ar Menashe Mental Health CenterLead Sponsor
Tirat Carmel Mental Health CenterCollaborator
Investigators
2
Michael S Ritsher, MD, PhDStudy Chair
Anatoly Kreinin, MD, PhdStudy Director
Sites
1 total
Hadera, Israel
Facts & assertions
4 sourced
Enrollment
60
Phase
PHASE4
Primary Completion Date
2010-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator